Additionally, mTOR inhibitors have been shown to induce apoptosis and wild-type p53 expression in two separate in vivo models of HNSCC [47], while the inhibition of Akt reversed the direct suppression of p53 by transcriptional and post-translational mechanisms. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.